Bulgaria vs Türkiye: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bulgaria
0.0%
in 2024
Türkiye
0.0%
in 2024
Bulgaria rank
168th
Türkiye rank
168th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bulgaria
- Türkiye
How they compare
Bulgaria currently reports 0.0% against 0.0% in Türkiye, a difference of 0.0%.
Across all 10 years both countries report, Türkiye has been ahead every year.
Bulgaria ranks 168th and Türkiye ranks 168th of 247 countries.
Türkiye has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Türkiye |
| 2020s | 0.0% | 0.1% | 0.1% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bulgaria or Türkiye?
- Bulgaria, at 0.0% against 0.0% in Türkiye as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bulgaria and Türkiye?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Bulgaria and Türkiye rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bulgaria ranks 168th and Türkiye ranks 168th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.